Agenus Inc (NASDAQ:AGEN) price closed lower on Monday, April 15, dropping -20.25% below its previous close.
A look at the daily price movement shows that the last close reads $8.15. The company’s 5Y monthly beta was ticking 1.28. Taking into account the 52-week price action we note that the stock hit a 52-week high of $42.60 and 52-week low of $7.02. The stock subtracted -45.81% on its value in the past month.
Agenus Inc, which has a market valuation of $136.17 million, is expected to release its quarterly earnings report May 07, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give AGEN a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that AGEN’s price is at present -37.59% off the SMA20 and -48.00% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 23.95, with weekly volatility standing at 19.17%. The indicator jumps to 11.83% when calculated based on the past 30 days. Agenus Inc (NASDAQ:AGEN)’s beta value is holding at 1.33, while the average true range (ATR) indicator is currently reading 1.28.
An analysis of the Agenus Inc (NASDAQ:AGEN) stock in terms of its daily trading volume indicates that the 3-month average is 553.66K.
Current records show that the company has 20.95M in outstanding shares. The insiders’ percentage holdings are 4.93% of outstanding shares. But the -60.74% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
